The involvement of S100A11 in AD pathogenesis is as follows: IL-4 and IL-13 downregulate S100A11 expression in keratinocytes, which also influences the upregulation of filaggrin and human beta-defensin 3 expression, indicating the role of the skin barrier function of S100A11 [89]. The gene discussed is IL13; the disease is Alzheimer disease.